Early Phase Study of KESONOTIDE™in Participants With Solid Tumours — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours — Stella

Recruiting

Back to Prostate Cancers trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

Australia

St George Private Hospital, Kogarah, New South Wales

South Western Sydney Local Health District, Liverpool, New South Wales

Southside Cancer Centre, Miranda, New South Wales

Key details

Phase

Early testing / Safety & dosing

Sponsor

Filamon LTD

Enrollment target

~80 participants

Started

November 2025

Primary completion

October 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov